5 Best Pharmaceutical Stocks to Buy According to Billionaire Joseph Edelman
In this article, we discuss the 5 best pharmaceutical stocks to buy according to billionaire Joseph Edelman.
Agile Therapeutics Inc (AGRX)
Market is closed
News
- First
- << Previous
- 11 - 20
- Next >>
Is Agile Therapeutics Inc (AGRX) A Good Stock To Buy?
As we already know from media reports and hedge fund investor letters, hedge funds delivered their best returns in a decade.
Is AGRX A Good Stock To Buy Now?
Although the masses and most of the financial media blame hedge funds for their exorbitant fee structure and disappointing performance, these investors have proved to have great stock picking abilities...
Hedge Funds Have Never Been This Bullish On Agile Therapeutics Inc (AGRX)
We at Insider Monkey have gone over 821 13F filings that hedge funds and prominent investors are required to file by the SEC The 13F filings show the funds' and investors' portfolio positions as of March...
Hedge Funds Have Never Been More Bullish On Agile Therapeutics Inc (AGRX)
Amid an overall bull market, many stocks that smart money investors were collectively bullish on surged through the end of November.
13D Filing: Aisling Capital III LP and Agile Therapeutics Inc (AGRX)
If the filing person has previously filed a statement on Schedule 13G to report the acquisition that is the subject of this Schedule 13D, and is filing this schedule because of §§240.13d-1(e), 240.13d...
13G Filing: Perceptive Advisors and Agile Therapeutics Inc (AGRX)
Reporting Person is set forth in Rows 5 through 9 and 11 of the cover page to this Schedule 13G.
Here's Why Apple, Tesla, and Three Other Stocks Are Trending
With the new investing year having just begun, plenty of meaningful events have caused major stocks such as Apple Inc.
How Agile Therapeutics Inc (AGRX) Stacks Up Against Its Peers
Hedge funds run by legendary names like Nelson Peltz and David Tepper make billions of dollars a year for themselves and their super-rich accredited investors (you’ve got to have a minimum of $1 million...
Agile Therapeutics Inc (AGRX) Stock: Aisling Capital Unloads 300,000 Shares
In a new 13D filing, Dennis Purcell's Aisling Capital reported lowering its stake in Agile Therapeutics Inc (NASDAQ:AGRX) to 2.28 million shares, which account for 7.9% of the company's outstanding ...
- First
- << Previous
- 11 - 20
- Next >>
Billionaire Hedge Funds
